 | • レポートコード：MRC2-11QY12318 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は免疫療法薬のグローバル市場について調査・分析したレポートです。種類別（モノクローナル抗体、成人用ワクチン、チェックポイント阻害剤、インターフェロンアルファ・ベータ、インターロイキン、その他）市場規模、用途別（がん、自己免疫・炎症性疾患、感染症、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別免疫療法薬の競争状況、市場シェア ・世界の免疫療法薬市場：種類別市場規模 2015年-2020年（モノクローナル抗体、成人用ワクチン、チェックポイント阻害剤、インターフェロンアルファ・ベータ、インターロイキン、その他） ・世界の免疫療法薬市場：種類別市場規模予測 2021年-2026年（モノクローナル抗体、成人用ワクチン、チェックポイント阻害剤、インターフェロンアルファ・ベータ、インターロイキン、その他） ・世界の免疫療法薬市場：用途別市場規模 2015年-2020年（がん、自己免疫・炎症性疾患、感染症、その他） ・世界の免疫療法薬市場：用途別市場規模予測 2021年-2026年（がん、自己免疫・炎症性疾患、感染症、その他） ・北米の免疫療法薬市場分析：米国、カナダ ・ヨーロッパの免疫療法薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの免疫療法薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の免疫療法薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの免疫療法薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Roche、Merck、Novartis、Johnson & Johnson、Glaxosmithkline、Amgen、Abbvie、Astrazeneca、Bristol-Myers Squibb、ELI Lilly ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Immunotherapy is a type of cancer treatment that helps your immune system fight cancer. The immune system helps your body fight infections and other diseases. It is made up of white blood cells and organs and tissues of the lymph system.
North America is expected to account for largest share in the immunotherapy drugs market, by region in 2018. Asia-Pacific is expected to be the fastest-growing regional segment in the market. The high growth of this segment can primarily be attributed to the low cost of manufacturing and acceptable regulatory scenario in this region.
Market Analysis and Insights: Global Immunotherapy Drugs Market
The global Immunotherapy Drugs market size is projected to reach US$ 199720 million by 2026, from US$ 178880 million in 2020, at a CAGR of 10.6%% during 2021-2026.
Global Immunotherapy Drugs Scope and Market Size
Immunotherapy Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Immunotherapy Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Roche
Merck
Novartis
Johnson & Johnson
Glaxosmithkline
Amgen
Abbvie
Astrazeneca
Bristol-Myers Squibb
ELI Lilly
Market segment by Type, the product can be split into
Monoclonal Antibodies
Adult Vaccines
Checkpoint Inhibitors
Interferons Alpha & Beta
Interleukins
Others
Market segment by Application, split into
Cancer
Autoimmune & Inflammatory Diseases
Infectious Diseases
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Immunotherapy Drugs Revenue
1.4 Market by Type
1.4.1 Global Immunotherapy Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Monoclonal Antibodies
1.4.3 Adult Vaccines
1.4.4 Checkpoint Inhibitors
1.4.5 Interferons Alpha & Beta
1.4.6 Interleukins
1.4.7 Others
1.5 Market by Application
1.5.1 Global Immunotherapy Drugs Market Share by Application: 2020 VS 2026
1.5.2 Cancer
1.5.3 Autoimmune & Inflammatory Diseases
1.5.4 Infectious Diseases
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Immunotherapy Drugs Market Perspective (2015-2026)
2.2 Global Immunotherapy Drugs Growth Trends by Regions
2.2.1 Immunotherapy Drugs Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Immunotherapy Drugs Historic Market Share by Regions (2015-2020)
2.2.3 Immunotherapy Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Immunotherapy Drugs Market Growth Strategy
2.3.6 Primary Interviews with Key Immunotherapy Drugs Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Immunotherapy Drugs Players by Market Size
3.1.1 Global Top Immunotherapy Drugs Players by Revenue (2015-2020)
3.1.2 Global Immunotherapy Drugs Revenue Market Share by Players (2015-2020)
3.1.3 Global Immunotherapy Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Immunotherapy Drugs Market Concentration Ratio
3.2.1 Global Immunotherapy Drugs Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Immunotherapy Drugs Revenue in 2019
3.3 Immunotherapy Drugs Key Players Head office and Area Served
3.4 Key Players Immunotherapy Drugs Product Solution and Service
3.5 Date of Enter into Immunotherapy Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Immunotherapy Drugs Historic Market Size by Type (2015-2020)
4.2 Global Immunotherapy Drugs Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Immunotherapy Drugs Market Size by Application (2015-2020)
5.2 Global Immunotherapy Drugs Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Immunotherapy Drugs Market Size (2015-2020)
6.2 Immunotherapy Drugs Key Players in North America (2019-2020)
6.3 North America Immunotherapy Drugs Market Size by Type (2015-2020)
6.4 North America Immunotherapy Drugs Market Size by Application (2015-2020)
7 Europe
7.1 Europe Immunotherapy Drugs Market Size (2015-2020)
7.2 Immunotherapy Drugs Key Players in Europe (2019-2020)
7.3 Europe Immunotherapy Drugs Market Size by Type (2015-2020)
7.4 Europe Immunotherapy Drugs Market Size by Application (2015-2020)
8 China
8.1 China Immunotherapy Drugs Market Size (2015-2020)
8.2 Immunotherapy Drugs Key Players in China (2019-2020)
8.3 China Immunotherapy Drugs Market Size by Type (2015-2020)
8.4 China Immunotherapy Drugs Market Size by Application (2015-2020)
9 Japan
9.1 Japan Immunotherapy Drugs Market Size (2015-2020)
9.2 Immunotherapy Drugs Key Players in Japan (2019-2020)
9.3 Japan Immunotherapy Drugs Market Size by Type (2015-2020)
9.4 Japan Immunotherapy Drugs Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Immunotherapy Drugs Market Size (2015-2020)
10.2 Immunotherapy Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Immunotherapy Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Immunotherapy Drugs Market Size by Application (2015-2020)
11 India
11.1 India Immunotherapy Drugs Market Size (2015-2020)
11.2 Immunotherapy Drugs Key Players in India (2019-2020)
11.3 India Immunotherapy Drugs Market Size by Type (2015-2020)
11.4 India Immunotherapy Drugs Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Immunotherapy Drugs Market Size (2015-2020)
12.2 Immunotherapy Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Immunotherapy Drugs Market Size by Type (2015-2020)
12.4 Central & South America Immunotherapy Drugs Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Roche
13.1.1 Roche Company Details
13.1.2 Roche Business Overview
13.1.3 Roche Immunotherapy Drugs Introduction
13.1.4 Roche Revenue in Immunotherapy Drugs Business (2015-2020))
13.1.5 Roche Recent Development
13.2 Merck
13.2.1 Merck Company Details
13.2.2 Merck Business Overview
13.2.3 Merck Immunotherapy Drugs Introduction
13.2.4 Merck Revenue in Immunotherapy Drugs Business (2015-2020)
13.2.5 Merck Recent Development
13.3 Novartis
13.3.1 Novartis Company Details
13.3.2 Novartis Business Overview
13.3.3 Novartis Immunotherapy Drugs Introduction
13.3.4 Novartis Revenue in Immunotherapy Drugs Business (2015-2020)
13.3.5 Novartis Recent Development
13.4 Johnson & Johnson
13.4.1 Johnson & Johnson Company Details
13.4.2 Johnson & Johnson Business Overview
13.4.3 Johnson & Johnson Immunotherapy Drugs Introduction
13.4.4 Johnson & Johnson Revenue in Immunotherapy Drugs Business (2015-2020)
13.4.5 Johnson & Johnson Recent Development
13.5 Glaxosmithkline
13.5.1 Glaxosmithkline Company Details
13.5.2 Glaxosmithkline Business Overview
13.5.3 Glaxosmithkline Immunotherapy Drugs Introduction
13.5.4 Glaxosmithkline Revenue in Immunotherapy Drugs Business (2015-2020)
13.5.5 Glaxosmithkline Recent Development
13.6 Amgen
13.6.1 Amgen Company Details
13.6.2 Amgen Business Overview
13.6.3 Amgen Immunotherapy Drugs Introduction
13.6.4 Amgen Revenue in Immunotherapy Drugs Business (2015-2020)
13.6.5 Amgen Recent Development
13.7 Abbvie
13.7.1 Abbvie Company Details
13.7.2 Abbvie Business Overview
13.7.3 Abbvie Immunotherapy Drugs Introduction
13.7.4 Abbvie Revenue in Immunotherapy Drugs Business (2015-2020)
13.7.5 Abbvie Recent Development
13.8 Astrazeneca
13.8.1 Astrazeneca Company Details
13.8.2 Astrazeneca Business Overview
13.8.3 Astrazeneca Immunotherapy Drugs Introduction
13.8.4 Astrazeneca Revenue in Immunotherapy Drugs Business (2015-2020)
13.8.5 Astrazeneca Recent Development
13.9 Bristol-Myers Squibb
13.9.1 Bristol-Myers Squibb Company Details
13.9.2 Bristol-Myers Squibb Business Overview
13.9.3 Bristol-Myers Squibb Immunotherapy Drugs Introduction
13.9.4 Bristol-Myers Squibb Revenue in Immunotherapy Drugs Business (2015-2020)
13.9.5 Bristol-Myers Squibb Recent Development
13.10 ELI Lilly
13.10.1 ELI Lilly Company Details
13.10.2 ELI Lilly Business Overview
13.10.3 ELI Lilly Immunotherapy Drugs Introduction
13.10.4 ELI Lilly Revenue in Immunotherapy Drugs Business (2015-2020)
13.10.5 ELI Lilly Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Immunotherapy Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Immunotherapy Drugs Revenue
Table 3. Ranking of Global Top Immunotherapy Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Immunotherapy Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Monoclonal Antibodies
Table 6. Key Players of Adult Vaccines
Table 7. Key Players of Checkpoint Inhibitors
Table 8. Key Players of Interferons Alpha & Beta
Table 9. Key Players of Interleukins
Table 10. Key Players of Others
Table 11. Global Immunotherapy Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 12. Global Immunotherapy Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 13. Global Immunotherapy Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 14. Global Immunotherapy Drugs Market Share by Regions (2015-2020)
Table 15. Global Immunotherapy Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 16. Global Immunotherapy Drugs Market Share by Regions (2021-2026)
Table 17. Market Top Trends
Table 18. Key Drivers: Impact Analysis
Table 19. Key Challenges
Table 20. Immunotherapy Drugs Market Growth Strategy
Table 21. Main Points Interviewed from Key Immunotherapy Drugs Players
Table 22. Global Immunotherapy Drugs Revenue by Players (2015-2020) (Million US$)
Table 23. Global Immunotherapy Drugs Market Share by Players (2015-2020)
Table 24. Global Top Immunotherapy Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immunotherapy Drugs as of 2019)
Table 25. Global Immunotherapy Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 26. Key Players Headquarters and Area Served
Table 27. Key Players Immunotherapy Drugs Product Solution and Service
Table 28. Date of Enter into Immunotherapy Drugs Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Immunotherapy Drugs Market Size by Type (2015-2020) (Million US$)
Table 31. Global Immunotherapy Drugs Market Size Share by Type (2015-2020)
Table 32. Global Immunotherapy Drugs Revenue Market Share by Type (2021-2026)
Table 33. Global Immunotherapy Drugs Market Size Share by Application (2015-2020)
Table 34. Global Immunotherapy Drugs Market Size by Application (2015-2020) (Million US$)
Table 35. Global Immunotherapy Drugs Market Size Share by Application (2021-2026)
Table 36. North America Key Players Immunotherapy Drugs Revenue (2019-2020) (Million US$)
Table 37. North America Key Players Immunotherapy Drugs Market Share (2019-2020)
Table 38. North America Immunotherapy Drugs Market Size by Type (2015-2020) (Million US$)
Table 39. North America Immunotherapy Drugs Market Share by Type (2015-2020)
Table 40. North America Immunotherapy Drugs Market Size by Application (2015-2020) (Million US$)
Table 41. North America Immunotherapy Drugs Market Share by Application (2015-2020)
Table 42. Europe Key Players Immunotherapy Drugs Revenue (2019-2020) (Million US$)
Table 43. Europe Key Players Immunotherapy Drugs Market Share (2019-2020)
Table 44. Europe Immunotherapy Drugs Market Size by Type (2015-2020) (Million US$)
Table 45. Europe Immunotherapy Drugs Market Share by Type (2015-2020)
Table 46. Europe Immunotherapy Drugs Market Size by Application (2015-2020) (Million US$)
Table 47. Europe Immunotherapy Drugs Market Share by Application (2015-2020)
Table 48. China Key Players Immunotherapy Drugs Revenue (2019-2020) (Million US$)
Table 49. China Key Players Immunotherapy Drugs Market Share (2019-2020)
Table 50. China Immunotherapy Drugs Market Size by Type (2015-2020) (Million US$)
Table 51. China Immunotherapy Drugs Market Share by Type (2015-2020)
Table 52. China Immunotherapy Drugs Market Size by Application (2015-2020) (Million US$)
Table 53. China Immunotherapy Drugs Market Share by Application (2015-2020)
Table 54. Japan Key Players Immunotherapy Drugs Revenue (2019-2020) (Million US$)
Table 55. Japan Key Players Immunotherapy Drugs Market Share (2019-2020)
Table 56. Japan Immunotherapy Drugs Market Size by Type (2015-2020) (Million US$)
Table 57. Japan Immunotherapy Drugs Market Share by Type (2015-2020)
Table 58. Japan Immunotherapy Drugs Market Size by Application (2015-2020) (Million US$)
Table 59. Japan Immunotherapy Drugs Market Share by Application (2015-2020)
Table 60. Southeast Asia Key Players Immunotherapy Drugs Revenue (2019-2020) (Million US$)
Table 61. Southeast Asia Key Players Immunotherapy Drugs Market Share (2019-2020)
Table 62. Southeast Asia Immunotherapy Drugs Market Size by Type (2015-2020) (Million US$)
Table 63. Southeast Asia Immunotherapy Drugs Market Share by Type (2015-2020)
Table 64. Southeast Asia Immunotherapy Drugs Market Size by Application (2015-2020) (Million US$)
Table 65. Southeast Asia Immunotherapy Drugs Market Share by Application (2015-2020)
Table 66. India Key Players Immunotherapy Drugs Revenue (2019-2020) (Million US$)
Table 67. India Key Players Immunotherapy Drugs Market Share (2019-2020)
Table 68. India Immunotherapy Drugs Market Size by Type (2015-2020) (Million US$)
Table 69. India Immunotherapy Drugs Market Share by Type (2015-2020)
Table 70. India Immunotherapy Drugs Market Size by Application (2015-2020) (Million US$)
Table 71. India Immunotherapy Drugs Market Share by Application (2015-2020)
Table 72. Central & South America Key Players Immunotherapy Drugs Revenue (2019-2020) (Million US$)
Table 73. Central & South America Key Players Immunotherapy Drugs Market Share (2019-2020)
Table 74. Central & South America Immunotherapy Drugs Market Size by Type (2015-2020) (Million US$)
Table 75. Central & South America Immunotherapy Drugs Market Share by Type (2015-2020)
Table 76. Central & South America Immunotherapy Drugs Market Size by Application (2015-2020) (Million US$)
Table 77. Central & South America Immunotherapy Drugs Market Share by Application (2015-2020)
Table 78. Roche Company Details
Table 79. Roche Business Overview
Table 80. Roche Product
Table 81. Roche Revenue in Immunotherapy Drugs Business (2015-2020) (Million US$)
Table 82. Roche Recent Development
Table 83. Merck Company Details
Table 84. Merck Business Overview
Table 85. Merck Product
Table 86. Merck Revenue in Immunotherapy Drugs Business (2015-2020) (Million US$)
Table 87. Merck Recent Development
Table 88. Novartis Company Details
Table 89. Novartis Business Overview
Table 90. Novartis Product
Table 91. Novartis Revenue in Immunotherapy Drugs Business (2015-2020) (Million US$)
Table 92. Novartis Recent Development
Table 93. Johnson & Johnson Company Details
Table 94. Johnson & Johnson Business Overview
Table 95. Johnson & Johnson Product
Table 96. Johnson & Johnson Revenue in Immunotherapy Drugs Business (2015-2020) (Million US$)
Table 97. Johnson & Johnson Recent Development
Table 98. Glaxosmithkline Company Details
Table 99. Glaxosmithkline Business Overview
Table 100. Glaxosmithkline Product
Table 101. Glaxosmithkline Revenue in Immunotherapy Drugs Business (2015-2020) (Million US$)
Table 102. Glaxosmithkline Recent Development
Table 103. Amgen Company Details
Table 104. Amgen Business Overview
Table 105. Amgen Product
Table 106. Amgen Revenue in Immunotherapy Drugs Business (2015-2020) (Million US$)
Table 107. Amgen Recent Development
Table 108. Abbvie Company Details
Table 109. Abbvie Business Overview
Table 110. Abbvie Product
Table 111. Abbvie Revenue in Immunotherapy Drugs Business (2015-2020) (Million US$)
Table 112. Abbvie Recent Development
Table 113. Astrazeneca Business Overview
Table 114. Astrazeneca Product
Table 115. Astrazeneca Company Details
Table 116. Astrazeneca Revenue in Immunotherapy Drugs Business (2015-2020) (Million US$)
Table 117. Astrazeneca Recent Development
Table 118. Bristol-Myers Squibb Company Details
Table 119. Bristol-Myers Squibb Business Overview
Table 120. Bristol-Myers Squibb Product
Table 121. Bristol-Myers Squibb Revenue in Immunotherapy Drugs Business (2015-2020) (Million US$)
Table 122. Bristol-Myers Squibb Recent Development
Table 123. ELI Lilly Company Details
Table 124. ELI Lilly Business Overview
Table 125. ELI Lilly Product
Table 126. ELI Lilly Revenue in Immunotherapy Drugs Business (2015-2020) (Million US$)
Table 127. ELI Lilly Recent Development
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Immunotherapy Drugs Market Share by Type: 2020 VS 2026
Figure 2. Monoclonal Antibodies Features
Figure 3. Adult Vaccines Features
Figure 4. Checkpoint Inhibitors Features
Figure 5. Interferons Alpha & Beta Features
Figure 6. Interleukins Features
Figure 7. Others Features
Figure 8. Global Immunotherapy Drugs Market Share by Application: 2020 VS 2026
Figure 9. Cancer Case Studies
Figure 10. Autoimmune & Inflammatory Diseases Case Studies
Figure 11. Infectious Diseases Case Studies
Figure 12. Others Case Studies
Figure 13. Immunotherapy Drugs Report Years Considered
Figure 14. Global Immunotherapy Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 15. Global Immunotherapy Drugs Market Share by Regions: 2020 VS 2026
Figure 16. Global Immunotherapy Drugs Market Share by Regions (2021-2026)
Figure 17. Porter's Five Forces Analysis
Figure 18. Global Immunotherapy Drugs Market Share by Players in 2019
Figure 19. Global Top Immunotherapy Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immunotherapy Drugs as of 2019
Figure 20. The Top 10 and 5 Players Market Share by Immunotherapy Drugs Revenue in 2019
Figure 21. North America Immunotherapy Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Europe Immunotherapy Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. China Immunotherapy Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Japan Immunotherapy Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Southeast Asia Immunotherapy Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. India Immunotherapy Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Central & South America Immunotherapy Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Bottom-up and Top-down Approaches for This Report
Figure 29. Data Triangulation
Figure 30. Key Executives Interviewed
頭頸部がん治療薬/治療の世界市場（～2026年） Head and neck cancer is a group of cancers that starts in the mouth, nose, throat, larynx, sinuses, or salivary glands. Current trends indicate that rising geriatric population worldwide, growing cases of target diseases, and availability of improved healthcare services due to government and private…- 舌下アレルギー免疫療法の世界市場（～2026年） Sublingual Allergy Immunotherapy is a method of treating allergies by giving a drug under the tongue. Market Analysis and Insights: Global Sublingual Allergy Immunotherapy Market The global Sublingual Allergy Immunotherapy market size is projected to reach US$ XX million by 2026, from US$ XX million…
- 腫瘍溶解性ウイルス免疫療法の世界市場（～2026年） Oncology Immunotherapy exploits virus's ability to replicate selectively and kill tumor tissue while at the same time regulate the specific immune response of a patient The first oncolytic virus to demonstrate a clinical benefit in patients with melanoma is genetically modified herpes simplex virus …
- 自己免疫治療薬の世界市場（～2026年） Abnormal immune responses of the innate immune system can cause autoimmune diseases, which can damage body tissues and lead to abnormal organ functions. Immunological complications due to physiological processes within the human body lead to autoimmune diseases. These diseases are characterized by c…
- 腎臓/腎がん治療薬の世界市場（～2026年） Kidney/Renal Cancer Drugs are used to cure kidney cancers. The market is primarily driven by lifestyle affecting factors such as reduced physical activity, excessive smoking and drinking. Rising aging population and the mounting prevalence of kidney cancer cases are some of the additional factors bo…